Publication & Citation Trends
Publications
0 total
Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling OA
Cited by 5
Semantic Scholar
Abstract 2150: LKB1 loss rewires JNK-induced apoptotic protein dynamics through NUAKs and sensitizes KRAS-mutant non-small cell lung cancers to combined KRAS G12C + MCL-1 blockade
Cited by 0
Semantic Scholar
Abstract 982:LKB1loss rewires stress signaling-induced apoptotic protein dynamics and sensitizesKRAS-mutant non-small cell lung cancers to combined MAPK + MCL-1 blockade
Cited by 0
Semantic Scholar
Abstract 1050: Efficacy of AMG 176 in combination with gilteritinib in preclinical models of acute myeloid leukemia
Cited by 0
Semantic Scholar
Abstract 1057: Combination of the KRASG12Cinhibitor sotorasib with targeted agents improves anti-tumor efficacy inKRAS p.G12Ccancer models
Cited by 0
Semantic Scholar
Abstract 1285:In vitrocharacterization of sotorasib and other RAS ‘His95-groove' binders and investigation of resistance mechanisms
Cited by 1
Semantic Scholar
Abstract IA20: Unlocked groove—developing covalent inhibitors of KRASG12C
Cited by 0
Semantic Scholar
Discovery of a covalent inhibitor of KRASG12C (AMG 510) for the treatment of solid tumors. OA
Cited by 586
Semantic Scholar
Research Topics
Liver physiology and pathology
(37)
Cancer, Hypoxia, and Metabolism
(36)
Cancer Mechanisms and Therapy
(26)
Renal cell carcinoma treatment
(23)
Cancer, Lipids, and Metabolism
(18)
Affiliations
Indiana University Health
Van Andel Institute
Amgen (United States)
University of California, San Francisco
Université Bourgogne Franche-Comté